In a recent study, U.S. researchers have reprogrammed cells found in circulating blood into cells that are molecularly and functionally indistinguishable from embryonic stem cells, a revolutionary achievement that provides a readily accessible source of stem cells and an alternative to harvesting embryonic stem cells.
Embryonic stem cells have long been coveted for their potential to treat a multitude of diseases, as a result of their unique properties of nearly indefinite self-renewal. (source: hematology.org)
|